Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innospec (IOSP) Receivables (2016 - 2025)

Innospec (IOSP) has disclosed Receivables for 16 consecutive years, with $342.3 million as the latest value for Q4 2025.

  • Quarterly Receivables changed 0.18% to $342.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $342.3 million through Dec 2025, changed 0.18% year-over-year, with the annual reading at $342.3 million for FY2025, 0.18% changed from the prior year.
  • Receivables hit $342.3 million in Q4 2025 for Innospec, down from $349.5 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $359.8 million in Q4 2023 to a low of $247.9 million in Q1 2021.
  • Historically, Receivables has averaged $322.4 million across 5 years, with a median of $335.3 million in 2022.
  • Biggest YoY gain for Receivables was 46.85% in 2021; the steepest drop was 16.33% in 2021.
  • Year by year, Receivables stood at $284.5 million in 2021, then increased by 17.61% to $334.6 million in 2022, then increased by 7.53% to $359.8 million in 2023, then fell by 5.03% to $341.7 million in 2024, then grew by 0.18% to $342.3 million in 2025.
  • Business Quant data shows Receivables for IOSP at $342.3 million in Q4 2025, $349.5 million in Q3 2025, and $336.1 million in Q2 2025.